Interestingly, the effect of the tumor-activated versus control SCs on SCLC cell invasiveness was significantly higher, and this was associated with a higher level of expression of several genes, including the STAT3, SOCS3, BCL6, ELF3, IGF2, and IL32 genes, in SCLC cells. This evidence concerns the gene BCL6 and small cell lung carcinoma.